ERK1 as a Therapeutic Target for Dendritic Cell Vaccination against High-Grade Gliomas.
Ku MC, Edes I, Bendix I, Pohlmann A, Waiczies H, Prozorovski T, Günther M, Martin C, Pagès G, Wolf SA, Kettenmann H, Uckert W, Niendorf T, Waiczies S.
Ku MC, et al. Among authors: pohlmann a.
Mol Cancer Ther. 2016 Aug;15(8):1975-87. doi: 10.1158/1535-7163.MCT-15-0850. Epub 2016 Jun 2.
Mol Cancer Ther. 2016.
PMID: 27256374